Colossal Biosciences, a startup focused on de-extinction of the woolly mammoth, is reportedly in talks to raise new capital at a valuation between $20 billion and $30 billion.
According to a report, the company is seeking at least a $20 billion valuation in the upcoming fundraising round.
If achieved, the new valuation would double or triple Colossal's previous valuation, as reported.
$20B–$30B
Colossal's reported target valuation in new fundraising talks.
$20B
Minimum valuation Colossal is reportedly seeking.
